Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome ; volume:11 ; number:1 ; day:30 ; month:9 ; year:2011 ; pages:1-8 ; date:12.2011
BMC infectious diseases ; 11, Heft 1 (30.9.2011), 1-8, 12.2011
- Urheber
-
Reboli, Annette C.
- Beteiligte Personen und Organisationen
-
Shorr, Andrew F.
Rotstein, Coleman
Pappas, Peter G.
Kett, Daniel H.
Schlamm, Haran T.
Reisman, Arlene L.
Biswas, Pinaki
Walsh, Thomas J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-11-261
- URN
-
urn:nbn:de:1111-2016030260387
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reboli, Annette C.
- Shorr, Andrew F.
- Rotstein, Coleman
- Pappas, Peter G.
- Kett, Daniel H.
- Schlamm, Haran T.
- Reisman, Arlene L.
- Biswas, Pinaki
- Walsh, Thomas J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
Moxidectin elevates Candida albicans ergosterol levels to synergize with polyenes against oral candidiasis
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
Recognition of Candida albicans and Role of Innate Type 17 Immunity in Oral Candidiasis
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
A new formulation of graphene oxide/fluconazole compound as a promising agent against Candida albicans
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
Moxidectin elevates Candida albicans ergosterol levels to synergize with polyenes against oral candidiasis
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
Recognition of Candida albicans and Role of Innate Type 17 Immunity in Oral Candidiasis
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
A new formulation of graphene oxide/fluconazole compound as a promising agent against Candida albicans
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
Moxidectin elevates Candida albicans ergosterol levels to synergize with polyenes against oral candidiasis
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
Recognition of Candida albicans and Role of Innate Type 17 Immunity in Oral Candidiasis
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species